[ad_1]
Vaccine mix in the United States. While the Americans approved the Moderna vaccine and were the first country in the world to have two vaccines, BioNTech partner Pfizer complains: There are millions of doses in our US warehouses, but no one knows where to go! !
The United States Food and Drug Administration (FDA) granted the Corona vaccine from the pharmaceutical company Moderna with emergency approval. The FDA announced on Friday. Use of the preparation could begin early next week. They expect that almost six million doses of vaccine can be distributed in the country immediately.
An advisory committee gave the FDA the green light Thursday for emergency approval of the US group’s corona vaccine. According to the information available so far, the advantages of the preparation in use by people 18 and older outweigh the risks, said 20 experts in a meeting held by video link.
“Congratulations, the Moderna vaccine is now available,” US President Donald Trump tweeted a few minutes after the FDA made the statement.
The Cambridge, Massachusetts-based company expects 20 million doses of the drug called “mRNA-1273” to be available in the United States by the end of the year. Production of 100 to 125 million doses of Moderna vaccine is expected in the first three months of next year. Of these, 15 to 25 million should be available outside the US.
Overall, the company expects to be able to manufacture up to 1 billion preparations worldwide in 2021.
Pifzer: sitting on liquid gold
At the same time, this news caused astonishment in the US yesterday: a dispute has broken out between the administration of Donald Trump (74) and the pharmaceutical company Pfizer, in which both parties point their fingers at the other.
More than a dozen of the country’s governors, mostly Democrats, had complained during the week that their vaccine supplies had been drastically reduced. The CDC’s Agency for Disease Prevention and Control had told them that deliveries of Pfizer BioNTech products would be up to 40 percent less than promised.
States affected: California, Hawaii, Nevada, Washington, Maine, Michigan, Connecticut, Montana, Illinois, Kansas (all Democrats), Georgia, Missouri, New Hampshire, Nebraska, Maryland, and Indiana (Republicans).
There was no explanation for the bottlenecks. But Donald Trump blamed manufacturers Pfizer and BioNTech. His health minister, Alex Azar, told CNBC that they had problems with production.
He said Pfizer had to cut its production from 100 million to 50 million cans by the end of the year. A message that, of course, is several weeks old. And he complained that the company, which, unlike Moderna and other drug companies, had not accepted government funding in the race for a vaccine, was not transparent to the government.
Pfizer responded shortly after, stating that there were no manufacturing problems. About 3 million cans were shipped in the first week after approval.
BUT: “Millions” of vaccine doses waited in vain for delivery instructions from the Trump administration. Therefore, the company is sitting on liquid gold, a warehouse that is filled with the COVID-19 vaccine. But the government does not know where they should be delivered.
A company spokesperson, according to the NPR radio station: “We still have millions of cans in our warehouse, but so far we have not received any shipping instructions.”
Additionally, “We remain confident that we can ship up to 50 million doses worldwide this year and up to 1.3 billion doses next year, and we look forward to continuing to work with the US government on our vaccine. to free the American people. “
